CIK 0001743881 · Large accelerated filer
BridgeBio Pharma, Inc.
Sign in to watch- Ticker
- BBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (650) 391-9740
- Business address
- 3160 PORTER DR., SUITE 250, PALO ALTO, CA, 94304
- Former names
- BridgeBio Pharma LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,563,798
- in 3 filings, $4.6M under 10b5-1 plans
Net −$4,563,798. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-09-05 | MCCORMICK FRANK Director | Option exercise | +74,000 | $11.92 | $882K | 157,275 |
| 2025-09-05 | MCCORMICK FRANK Director | Sale | −74,000 | $53.16 | $3.9M | 83,275 |
| 2025-09-05 | MCCORMICK FRANK Director | Option exercise · Stock Option (Right to Buy) | −74,000 | 84,814 | ||
| 2025-09-04 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −14,525 | $51.15 | $743K | 4,703,922 |
| 2025-09-04 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −5,475 | $51.85 | $284K | 4,698,447 |
| 2025-09-04 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −14,558 | $51.16 | $745K | 901,128 |
| 2025-09-04 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −5,442 | $51.85 | $282K | 895,686 |
| 2025-08-21 | Trimarchi Thomas President and CFO | Sale | −42,237 | $49.48 | $2.1M | 421,081 |
| 2025-08-20 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −25,728 | $48.81 | $1.3M | 223,518 |
| 2025-08-20 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −428 | $49.25 | $21K | 223,090 |
| 2025-08-18 | Trimarchi Thomas President and CFO | Sale 10b5-1 | −15,380 | $50.14 | $771K | 465,291 |
| 2025-08-18 | Trimarchi Thomas President and CFO | Sale 10b5-1 | −1,973 | $50.94 | $101K | 463,318 |
| 2025-08-16 | Apuli Maricel Chief Accounting Officer | Shares withheld for taxes | −4,781 | $51.32 | $245K | 137,078 |
| 2025-08-16 | Trimarchi Thomas President and CFO | Shares withheld for taxes 10b5-1 | −21,317 | $51.32 | $1.1M | 480,671 |
| 2025-08-16 | Kumar Neil Chief Executive Officer | Option exercise | +64,697 | 282,101 | ||
| 2025-08-16 | Kumar Neil Chief Executive Officer | Shares withheld for taxes | −32,855 | $51.32 | $1.7M | 249,246 |
| 2025-08-16 | Kumar Neil Chief Executive Officer | Option exercise · Restricted Stock Units | −33,544 | 201,264 | ||
| 2025-08-16 | Kumar Neil Chief Executive Officer | Option exercise · Restricted Stock Units | −19,599 | 195,993 | ||
| 2025-08-16 | Kumar Neil Chief Executive Officer | Option exercise · Restricted Stock Units | −11,554 | 161,753 | ||
| 2025-08-11 | HOMCY CHARLES J Director | Sale 10b5-1 | −50,000 | $48.00 | $2.4M | 916,674 |
Page 15 of 32 · 638 trades